Usage of Adenovirus Expressing Thymidine Kinase Mediated Hepatocellular Damage for Enabling Mouse Liver Repopulation with Allogenic or Xenogenic Hepatocytes

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Moreno, Daniel ^a   Balasiddaiah, Anangi ^a   Lamas, Oscar ^a,g   Duret, Cedric ^b,c,d   Neri, Leire ^a   Guembe, Laura ^a   Galarraga, Miguel ^a   Larrea, Esther ^a   Daujat Chavanieu, Martine ^b,c,d   Muntane, Jordi ^e,f   Maurel, Patrick ^b,c,d   Riezu, Jose Ignacio ^a   Prieto, Jesus ^a,f   Aldabe, Rafael ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

^d HÔPITAL SAINT ELOI   (France)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f UNIVERSITY CLINIC OF NAVARRA   (Spain)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ENROFLOXACIN; GANCICLOVIR; THYMIDINE KINASE; VIRUS DNA;

ADENOVIRUS; ADENOVIRUS INFECTION; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GERM LINE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL DAMAGE; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; VASCULARIZATION; XENOGRAFT;

ADENOVIRIDAE; ALBUMINS; ANIMALS; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; GANCICLOVIR; GREEN FLUORESCENT PROTEINS; HEPATITIS B; HEPATITIS C; HEPATOCYTES; HUMANS; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; LIVER; MALE; MICE; MICE, INBRED BALB C; THYMIDINE KINASE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84884542451     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074948     Document Type: Article

References (36)

1. Guguen-Guillouzo C, Guillouzo A, (2010) General review on in vitro hepatocyte models and their applications. Methods Mol Biol 640: 1-40. doi:10.1007/978-1-60761-688-7_1. PubMed: 20645044.
2. Elaut G, Henkens T, Papeleu P, Snykers S, Vinken M, et al. (2006) Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr Drug Metab 7: 629-660. doi:10.2174/138920006778017759. PubMed: 16918317.
3. Sheahan T, Jones CT, Ploss A, (2010) Advances and challenges in studying hepatitis C virus in its native environment. Expert Rev Gastroenterol Hepatol 4: 541-550. doi:10.1586/egh.10.53. PubMed: 20932139.
4. Yoshizato K, Tateno C, (2009) In vivo modeling of human liver for pharmacological study using humanized mouse. Expert Opin Drug Metab Toxicol 5: 1435-1446. doi:10.1517/17425250903216664. PubMed: 19715443.
5. Strom SC, Davila J, Grompe M, (2010) Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol 640: 491-509. doi:10.1007/978-1-60761-688-7_27. PubMed: 20645070.
6. Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, et al. (2010) Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 120: 924-930. doi:10.1172/JCI40094. PubMed: 20179355.
7. Rhim JA, Sandgren EP, Palmiter RD, Brinster RL, (1995) Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci U S A 92: 4942-4946. doi:10.1073/pnas.92.11.4942. PubMed: 7761429.
8. Dandri M, Burda MR, Török E, Pollok JM, Iwanska A, et al. (2001) Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33: 981-988. doi:10.1053/jhep.2001.23314. PubMed: 11283864.
9. Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao C, et al. (2001) Hepatitis C virus replication in mice with chimeric human livers. Nat Med 7: 927-933. doi:10.1038/90968. PubMed: 11479625.
10. Azuma H, Paulk N, Ranade A, Dorrell C, Al-Dhalimy M, et al. (2007) Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol 25: 903-910. doi:10.1038/nbt1326. PubMed: 17664939.
11. Gilgenkrantz H, (2010) Rodent models of liver repopulation. Methods Mol Biol 640: 475-490. doi:10.1007/978-1-60761-688-7_26. PubMed: 20645069.
12. Steenbergen RH, Joyce MA, Lund G, Lewis J, Chen R, et al. (2010) Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success. Am J Physiol Gastrointest Liver Physiol 299: G844-G854. doi:10.1152/ajpgi.00200.2010. PubMed: 20651006.
13. Tateno C, Yoshizane Y, Saito N, Kataoka M, Utoh R, et al. (2004) Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165: 901-912. doi:10.1016/S0002-9440(10)63352-4. PubMed: 15331414.
14. Lootens L, Van Eenoo P, Meuleman P, Pozo OJ, Van Renterghem P, et al. (2009) Steroid metabolism in chimeric mice with humanized liver. Drugs Test Anal 1: 531-537. doi:10.1002/dta.67. PubMed: 20355169.
15. Kamimura H, Nakada N, Suzuki K, Mera A, Souda K, et al. (2010) Assessment of chimeric mice with humanized liver as a tool for predicting circulating human metabolites. Drug Metab Pharmacokinet 25: 223-235. doi:10.2133/dmpk.25.223. PubMed: 20610881.
16. Okumura H, Katoh M, Sawada T, Nakajima M, Soeno Y, et al. (2007) Humanization of excretory pathway in chimeric mice with humanized liver. Toxicol Sci 97: 533-538. doi:10.1093/toxsci/kfm041. PubMed: 17341479.
17. Walters KA, Joyce MA, Thompson JC, Smith MW, Yeh MM, et al. (2006) Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response. PLOS Pathog 2: e59. doi:10.1371/journal.ppat.0020059. PubMed: 16789836.
18. Petersen J, Dandri M, Mier W, Lütgehetmann M, Volz T, et al. (2008) Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 26: 335-341. doi:10.1038/nbt1389. PubMed: 18297057.
19. Sugiyama M, Tanaka Y, Kurbanov F, Maruyama I, Shimada T, et al. (2009) Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology 136: 652-62.e3. PubMed: 19041311.
20. Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, et al. (2011) A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 140: 1334-1344. doi:10.1053/j.gastro.2011.01.001. PubMed: 21237170.
21. Meuleman P, Catanese MT, Verhoye L, Desombere I, Farhoudi A, et al. (2012) A human monoclonal antibody targeting SR-BI precludes hepatitis C virus infection and viral spread in vitro and in vivo. Hepatology 55: 364-372. doi:10.1002/hep.24692. PubMed: 21953761.
22. Meuleman P, Libbrecht L, De Vos R, de Hemptinne B, Gevaert K, et al. (2005) Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41: 847-856. doi:10.1002/hep.20657. PubMed: 15791625.
23. Tateno C, Kataoka M, Utoh R, Tachibana A, Itamoto T, et al. (2011) Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. Endocrinology 152: 1479-1491. doi:10.1210/en.2010-0953. PubMed: 21303949.
24. Utoh R, Tateno C, Kataoka M, Tachibana A, Masumoto N, et al. (2010) Hepatic hyperplasia associated with discordant xenogeneic parenchymal-nonparenchymal interactions in human hepatocyte-repopulated mice. Am J Pathol 177: 654-665. doi:10.2353/ajpath.2010.090430. PubMed: 20522646.
25. Peterson RA, Krull DL, Brown HR, de Serres M, (2010) Morphologic characterization of PhoenixBio (uPA+/+/SCID) humanized liver chimeric mouse model. Drugs Metabolism Lett 4: 180-184. doi:10.2174/187231210791698456. PubMed: 20642451.
26. Sato Y, Yamada H, Iwasaki K, Tateno C, Yokoi T, et al. (2008) Human hepatocytes can repopulate mouse liver: histopathology of the liver in human hepatocyte-transplanted chimeric mice and toxicologic responses to acetaminophen. Toxicol Pathol 36: 581-591. doi:10.1177/0192623308318212. PubMed: 18467679.
27. Braun KM, Degen JL, Sandgren EP, (2000) Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells. Nat Med 6: 320-326. doi:10.1038/73179. PubMed: 10700235.
28. Hasegawa M, Kawai K, Mitsui T, Taniguchi K, Monnai M, et al. (2011) The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem Biophys Res Commun 405: 405-410. doi:10.1016/j.bbrc.2011.01.042. PubMed: 21238430.
29. Pichard L, Raulet E, Fabre G, Ferrini JB, Ourlin JC, et al. (2006) Human hepatocyte culture. Methods Mol Biol 320: 283-293. PubMed: 16719400.
30. Loke SL, Leung CY, Chiu KY, Yau WL, Cheung KN, et al. (1990) Localisation of CD10 to biliary canaliculi by immunoelectron microscopical examination. J Clin Pathol 43: 654-656. doi:10.1136/jcp.43.8.654. PubMed: 2144860.
31. Vanwolleghem T, Libbrecht L, Hansen BE, Desombere I, Roskams T, et al. (2010) Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice. J Hepatol 53: 468-476. doi:10.1016/j.jhep.2010.03.024. PubMed: 20591528.
32. Bustos M, Sangro B, Alzuguren P, Gil AG, Ruiz J, et al. (2000) Liver damage using suicide genes. A model for oval cell activation. Am J Pathol 157: 549-559. doi:10.1016/S0002-9440(10)64565-8. PubMed: 10934157.
33. He Z, Zhang H, Zhang X, Xie D, Chen Y, et al. (2010) Liver xeno-repopulation with human hepatocytes in Fah-/-Rag2-/- mice after pharmacological immunosuppression. Am J Pathol 177: 1311-1319. doi:10.2353/ajpath.2010.091154. PubMed: 20651238.
34. Douglas DN, Kawahara T, Sis B, Bond D, Fischer KP, et al. (2010) Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease. PLOS ONE 5(2):: e9209. doi:10.1371/journal.pone.0009209. PubMed: 20174638.
35. Schulze A, Mills K, Weiss TS, Urban S, (2012) Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 55: 373-383. doi:10.1002/hep.24707. PubMed: 21953491.
36. Molina-Jimenez F, Benedicto I, Dao Thi VL, Gondar V, Lavillette D, et al. (2012) Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. Virology 425: 31-39. doi:10.1016/j.virol.2011.12.021. PubMed: 22280897.